Literature DB >> 6305129

Radiation therapy of recurrent nasopharyngeal carcinoma. Report on 219 patients.

J H Yan, Y H Hu, X Z Gu.   

Abstract

Recurrent nasopharyngeal carcinoma (NPC), if left untreated, has a 5-year survival of less than one per cent. In contrast, the overall 5-year survival in a treated series of patients was 18 per cent. Excluding those with distant metastases at the beginning of the retreatment, the 5-year survival was 23 per cent. If the recurrence was limited to the neck, a 5-year survival of 34 per cent was obtained and if it was confined to the nasopharynx the 5-year survival was 25 per cent. High doses (about 60 Gy), using multiple narrow beams, carefully directed, were required. For recurrences in the neck, lymph node dissection supplemented by a lower radiation dose should be considered. Surgery was sometimes the only possible method for cure, when recurrence occurred in the neck nodes. Recurrences in the neck, especially when repeatedly appearing, most often were combined with a local recurrence in the nasopharynx.

Entities:  

Mesh:

Year:  1983        PMID: 6305129     DOI: 10.3109/02841868309134335

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  8 in total

1.  Resection of persistent nasopharyngeal carcinoma.

Authors:  E Yumoto; K Gyo; N Yanagihara
Journal:  Skull Base Surg       Date:  1994

2.  Carcinoma of the nasopharynx--comparison of the UICC and Ho clinical staging systems.

Authors:  S L Roth; G Bertram; H Sack
Journal:  Klin Wochenschr       Date:  1989-01-20

Review 3.  Current treatment options for recurrent nasopharyngeal cancer.

Authors:  Carlos Suárez; Juan P Rodrigo; Alessandra Rinaldo; Johannes A Langendijk; Ashok R Shaha; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-24       Impact factor: 2.503

4.  Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.

Authors:  Ling Zhang; Yong-xue Zhu; Yu Wang; Cai-ping Huang; Yi Wu; Qing-hai Ji
Journal:  Ann Surg Oncol       Date:  2010-08-25       Impact factor: 5.344

5.  An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma.

Authors:  Xinying Shen; Yong Li; Yanfang Zhang; Jian Kong; Yanhao Li
Journal:  Onco Targets Ther       Date:  2015-05-02       Impact factor: 4.147

6.  Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma.

Authors:  Ying Guan; Shuai Liu; Han-Yu Wang; Ying Guo; Wei-Wei Xiao; Chun-Yan Chen; Chong Zhao; Tai-Xiang Lu; Fei Han
Journal:  Chin J Cancer       Date:  2016-02-15

7.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.

Authors:  Daniel T T Chua; Shao-Xiong Wu; Victor Lee; Janice Tsang
Journal:  Head Neck Oncol       Date:  2009-05-23

8.  Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison.

Authors:  Lei Wang; Jiyi Hu; Xiaoli Liu; Weiwei Wang; Lin Kong; Jiade J Lu
Journal:  Cancer Manag Res       Date:  2019-08-16       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.